$RXRX 8-K SEC Filings

Filed On	Filing
15 Oct 2026	8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +2 more Goldman Sachs & Co. LLCMorgan Stanley & Co. LLCEvercore Group L.L.C.,
21 Sep 2026	8-K: Entry into a Material Definitive Agreement Recursion Pharmaceuticals, Inc. (the "Company") and Tempus AI, Inc. ("Tempus"), acknowledging the value of (i) Tempus’s library of multimodal data and (ii) Recursion’s proprietary foundational RNA sequencing model (the "TxFM Model"), hav...
05 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
18 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
06 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
30 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
25 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
25 Feb 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
12 Jan 2026	8-K: Regulation FD Disclosure
08 Dec 2025	8-K: Other Events
26 Nov 2025	8-K: Other Events
05 Nov 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
29 Oct 2025	8-K: Other Events
05 Aug 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
08 Jul 2025	8-K: Unregistered Sales of Equity Securities; Regulation FD Disclosure +1 more
18 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
10 Jun 2025	8-K: Costs Associated with Exit or Disposal Activities; Regulation FD Disclosure
09 May 2025	8-K: Other Events
05 May 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
18 Mar 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure +1 more

Comments